Cargando…

Multisystemic Manifestations in Rare Diseases: The Experience of Dyskeratosis Congenita

Dyskeratosis congenital (DC) is the first genetic syndrome described among telomeropathies. Its classical phenotype is characterized by the mucocutaneous triad of reticulated pigmentation of skin lace, nail dystrophy and oral leukoplakia. The clinical presentation, however, is heterogeneous and seri...

Descripción completa

Detalles Bibliográficos
Autores principales: Callea, Michele, Martinelli, Diego, Cammarata-Scalisi, Francisco, Grimaldi, Chiara, Jilani, Houweyda, Grimaldi, Piercesare, Willoughby, Colin Eric, Morabito, Antonino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953471/
https://www.ncbi.nlm.nih.gov/pubmed/35328050
http://dx.doi.org/10.3390/genes13030496
_version_ 1784675859221708800
author Callea, Michele
Martinelli, Diego
Cammarata-Scalisi, Francisco
Grimaldi, Chiara
Jilani, Houweyda
Grimaldi, Piercesare
Willoughby, Colin Eric
Morabito, Antonino
author_facet Callea, Michele
Martinelli, Diego
Cammarata-Scalisi, Francisco
Grimaldi, Chiara
Jilani, Houweyda
Grimaldi, Piercesare
Willoughby, Colin Eric
Morabito, Antonino
author_sort Callea, Michele
collection PubMed
description Dyskeratosis congenital (DC) is the first genetic syndrome described among telomeropathies. Its classical phenotype is characterized by the mucocutaneous triad of reticulated pigmentation of skin lace, nail dystrophy and oral leukoplakia. The clinical presentation, however, is heterogeneous and serious clinical complications include bone marrow failure, hematological and solid tumors. It may also involve immunodeficiencies, dental, pulmonary and liver disorders, and other minor complication. Dyskeratosis congenita shows marked genetic heterogeneity, as at least 14 genes are responsible for the shortening of telomeres characteristic of this disease. This review discusses clinical characteristics, molecular genetics, disease evolution, available therapeutic options and differential diagnosis of dyskeratosis congenita to provide an interdisciplinary and personalized medical assessment that includes family genetic counseling.
format Online
Article
Text
id pubmed-8953471
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-89534712022-03-26 Multisystemic Manifestations in Rare Diseases: The Experience of Dyskeratosis Congenita Callea, Michele Martinelli, Diego Cammarata-Scalisi, Francisco Grimaldi, Chiara Jilani, Houweyda Grimaldi, Piercesare Willoughby, Colin Eric Morabito, Antonino Genes (Basel) Review Dyskeratosis congenital (DC) is the first genetic syndrome described among telomeropathies. Its classical phenotype is characterized by the mucocutaneous triad of reticulated pigmentation of skin lace, nail dystrophy and oral leukoplakia. The clinical presentation, however, is heterogeneous and serious clinical complications include bone marrow failure, hematological and solid tumors. It may also involve immunodeficiencies, dental, pulmonary and liver disorders, and other minor complication. Dyskeratosis congenita shows marked genetic heterogeneity, as at least 14 genes are responsible for the shortening of telomeres characteristic of this disease. This review discusses clinical characteristics, molecular genetics, disease evolution, available therapeutic options and differential diagnosis of dyskeratosis congenita to provide an interdisciplinary and personalized medical assessment that includes family genetic counseling. MDPI 2022-03-11 /pmc/articles/PMC8953471/ /pubmed/35328050 http://dx.doi.org/10.3390/genes13030496 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Callea, Michele
Martinelli, Diego
Cammarata-Scalisi, Francisco
Grimaldi, Chiara
Jilani, Houweyda
Grimaldi, Piercesare
Willoughby, Colin Eric
Morabito, Antonino
Multisystemic Manifestations in Rare Diseases: The Experience of Dyskeratosis Congenita
title Multisystemic Manifestations in Rare Diseases: The Experience of Dyskeratosis Congenita
title_full Multisystemic Manifestations in Rare Diseases: The Experience of Dyskeratosis Congenita
title_fullStr Multisystemic Manifestations in Rare Diseases: The Experience of Dyskeratosis Congenita
title_full_unstemmed Multisystemic Manifestations in Rare Diseases: The Experience of Dyskeratosis Congenita
title_short Multisystemic Manifestations in Rare Diseases: The Experience of Dyskeratosis Congenita
title_sort multisystemic manifestations in rare diseases: the experience of dyskeratosis congenita
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953471/
https://www.ncbi.nlm.nih.gov/pubmed/35328050
http://dx.doi.org/10.3390/genes13030496
work_keys_str_mv AT calleamichele multisystemicmanifestationsinrarediseasestheexperienceofdyskeratosiscongenita
AT martinellidiego multisystemicmanifestationsinrarediseasestheexperienceofdyskeratosiscongenita
AT cammaratascalisifrancisco multisystemicmanifestationsinrarediseasestheexperienceofdyskeratosiscongenita
AT grimaldichiara multisystemicmanifestationsinrarediseasestheexperienceofdyskeratosiscongenita
AT jilanihouweyda multisystemicmanifestationsinrarediseasestheexperienceofdyskeratosiscongenita
AT grimaldipiercesare multisystemicmanifestationsinrarediseasestheexperienceofdyskeratosiscongenita
AT willoughbycolineric multisystemicmanifestationsinrarediseasestheexperienceofdyskeratosiscongenita
AT morabitoantonino multisystemicmanifestationsinrarediseasestheexperienceofdyskeratosiscongenita